Condition
Cesarean Scar Niche
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Unknown2
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06466343Not ApplicableRecruitingPrimary
Immunohistopathologic Findings of Cesarean Scar Niche
NCT05777837Not ApplicableUnknownPrimary
Laparoscopic Versus Combined Laparoscopic and Hysteroscopic Repair of CS Niche
NCT03609281CompletedPrimary
Cesarean Scar Characteristics After Scheduled and Emergency Cesarean Deliveries
NCT02410395Not ApplicableUnknownPrimary
NIche Development With Closure of Cesarean Uterotomy by Modified or Conventional Two-layer Technique
NCT03257514Phase 2Completed
Effect of Alpha Lipoic Acid on Uterine Scar Healing After Cesarean Section
Showing all 5 trials